AZIYO BIOLOGICS INC's ticker is AZYO and the CUSIP is 05479K106. A total of 18 filers reported holding AZIYO BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $715 | -39.4% | 500 | 0.0% | 0.00% | – |
| Q2 2023 | $1,180 | +56.3% | 500 | 0.0% | 0.00% | – |
| Q1 2023 | $755 | -83.1% | 500 | -52.4% | 0.00% | – |
| Q4 2022 | $4,467 | -10.7% | 1,051 | +52.5% | 0.00% | – |
| Q3 2022 | $5,000 | +25.0% | 689 | +37.0% | 0.00% | – |
| Q2 2022 | $4,000 | -55.6% | 503 | -67.7% | 0.00% | – |
| Q1 2022 | $9,000 | -10.0% | 1,558 | -0.8% | 0.00% | – |
| Q4 2021 | $10,000 | -9.1% | 1,571 | -3.6% | 0.00% | – |
| Q3 2021 | $11,000 | -45.0% | 1,629 | -21.7% | 0.00% | – |
| Q2 2021 | $20,000 | -23.1% | 2,081 | +12.1% | 0.00% | – |
| Q1 2021 | $26,000 | +62.5% | 1,857 | +61.8% | 0.00% | – |
| Q4 2020 | $16,000 | – | 1,148 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 1,655,184 | $2,499 | 1.96% |
| PERKINS CAPITAL MANAGEMENT INC | 275,329 | $416 | 0.39% |
| Prosight Management, LP | 196,443 | $296,629 | 0.14% |
| Indie Asset Partners, LLC | 26,500 | $40,015 | 0.05% |
| Knollwood Investment Advisory, LLC | 58,962 | $89,033 | 0.02% |
| Alyeska Investment Group, L.P. | 214,343 | $323,658 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,134 | $8 | 0.00% |
| US BANCORP \DE\ | 625 | $944 | 0.00% |
| WELLS FARGO & COMPANY/MN | 56 | $85 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |